Skip to content
NJ News HubNewsHub

Health

Substance Use Disorder Resources Available

Source: CNBNews · Jul 27, 2026, 3:00 PM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

Substance Use Disorder Resources Available news image

New Jersey residents struggling with substance use disorder now have access to immediate, free support through a dedicated helpline.

The ReachNJ hotline (1-844-732-2465) connects callers with trained addiction counselors available around the clock, seven days a week.

The service assists both individuals battling addiction and loved ones seeking guidance. Additionally, naloxone (Narcan) is available to help prevent overdose deaths.

This resource represents a state-level commitment to addressing the opioid crisis and supporting residents in their recovery journey.

Key points

  • ReachNJ hotline operates 24/7 with live, trained addiction counselors based in New Jersey
  • Service is free and available to individuals struggling with addiction and their families
  • Naloxone (Narcan) is accessible through the program to prevent overdose deaths
  • Trained professionals provide immediate support and assistance to callers seeking help

FAQ

How do I reach the ReachNJ addiction helpline?
Call 1-844-ReachNJ (1-844-732-2465) anytime, day or night. The helpline is open 24 hours a day, 7 days a week with live addiction counselors ready to assist.
Is the helpline free and confidential?
Yes, the ReachNJ service is free and available to anyone seeking help with substance use disorder, whether for themselves or a loved one. Live counselors provide immediate support and guidance.
What is Narcan and why is it available through this program?
Narcan (naloxone) is a medication that can reverse opioid overdose and save lives. Making it accessible through the ReachNJ program helps prevent overdose deaths and supports harm reduction efforts in the community.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related